デフォルト表紙
市場調査レポート
商品コード
1698183

ヒト肝モデル市場- 世界の産業規模、シェア、動向、機会、予測、製品別（2Dモデル、3Dバイオプリンティング、肝臓器）、用途別（創薬、学術・調査）、地域別、競合別、2020-2030年

Human Liver Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (2D Models, 3D Bio Printing, Liver Organoids), By Application (Drug Discovery, Academics & Research), By Region & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
ヒト肝モデル市場- 世界の産業規模、シェア、動向、機会、予測、製品別（2Dモデル、3Dバイオプリンティング、肝臓器）、用途別（創薬、学術・調査）、地域別、競合別、2020-2030年
出版日: 2025年03月28日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

ヒト肝モデルの世界市場規模は2024年に6億1,595万米ドルとなり、予測期間のCAGRは4.12%で2030年まで安定した成長が予測されています。

世界ヒト肝モデル市場は、生物工学のブレークスルー、肝疾患有病率の上昇、より精密な薬物検査プラットフォームへのニーズの高まりによって急速に拡大しています。代謝性疾患、ウイルス性肝炎、アルコール関連肝疾患が急増を続ける中、製薬企業やバイオテクノロジー企業は、創薬、毒性スクリーニング、再生医療研究を強化するため、先進的な肝臓モデルに多額の投資を行っています。

市場概要
予測期間 2026-2030
市場規模：2024年 6億1,595万米ドル
市場規模：2030年 7億8,663万米ドル
CAGR：2025年～2030年 4.12%
急成長セグメント 2Dモデル
最大市場 北米

肝がんの罹患率は増加傾向にあり、死亡率も高いことから、より効果的で予測可能な研究モデルの緊急ニーズが高まっています。さらに、肝移植用のドナー臓器が不足していることから、バイオエンジニアリング肝組織や代替治療ソリューションの開発が加速しており、この分野の技術革新がさらに進んでいます。

主な市場促進要因

医薬品研究の進歩

主な市場課題

肝機能の複雑さ

主要市場動向

マルチ・オルガン・オンチップ・システム

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のヒト肝モデル市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別（2Dモデル、3Dバイオプリント、肝臓オルガノイド）
    • 用途別（創薬、学術・調査）
    • 地域別
    • 企業別（2024）
  • 製品市場マップ
    • 製品別
    • 用途別
    • 地域別

第6章 北米のヒト肝モデル市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のヒト肝モデル市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域のヒト肝モデル市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米のヒト肝モデル市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのヒト肝モデル市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Organovo Holdings Inc
  • BioIVT LLC
  • InSphero AG
  • Emulate Inc
  • Mimetas BV
  • CN Bio
  • Cyfuse Biomedical KK
  • Hurel Corp

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 17520

Global Human Liver Model Market was valued at USD 615.95 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 4.12% through 2030. The Global Human Liver Model Market is expanding rapidly, driven by breakthroughs in bioengineering, rising liver disease prevalence, and the growing need for more precise drug testing platforms. As metabolic disorders, viral hepatitis, and alcohol-related liver conditions continue to surge, pharmaceutical and biotechnology companies are making significant investments in advanced liver models to enhance drug discovery, toxicity screening, and regenerative medicine research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 615.95 Million
Market Size 2030USD 786.63 Million
CAGR 2025-20304.12%
Fastest Growing Segment2D Models
Largest MarketNorth America

The increasing incidence of liver cancer, coupled with high mortality rates, underscores the urgent need for more effective and predictive research models. Additionally, the shortage of donor organs for liver transplants has accelerated the development of bioengineered liver tissues and alternative therapeutic solutions, driving further innovation in the field.

Key Market Drivers

Pharmaceutical Research Advancements

The Global Human Liver Model Market is experiencing a transformative surge in demand, driven in large part by the rapid advancements in pharmaceutical research. As the pharmaceutical industry faces increasing pressure to develop safer and more effective drugs while reducing time and costs, human liver models have emerged as indispensable tools.

Pharmaceutical companies are continually searching for more efficient and accurate ways to evaluate drug candidates. Human liver models provide a realistic and dynamic environment to test potential drugs, predict their pharmacokinetics, and assess their toxicity. This level of precision significantly reduces the risk of late-stage clinical trial failures, leading to substantial cost savings and a more streamlined drug development process.

Key Market Challenges

Complexity of Liver Functionality

The liver is an incredibly complex organ with numerous functions, including detoxification, metabolism, and protein synthesis. Replicating all of its functions accurately in a model is challenging. Researchers are working on improving the physiological relevance of liver models, but achieving a complete emulation remains a formidable task.

Key Market Trends

Multi-Organ-on-a-Chip Systems

The development of multi-organ-on-a-chip systems is a groundbreaking trend. These platforms enable the study of interactions between the liver and other organs, providing a more comprehensive understanding of how drugs and diseases affect the entire human body. Such models hold immense promise for advancing drug development and personalized medicine.

Key Market Players

  • Organovo Holdings Inc
  • BioIVT LLC
  • InSphero AG
  • Emulate Inc
  • Mimetas BV
  • CN Bio
  • Cyfuse Biomedical KK
  • Hurel Corp

Report Scope:

In this report, the Global Human Liver Model Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Liver Model Market, By Product:

  • 2D Models
  • 3D Bio Printing
  • Liver Organoids

Human Liver Model Market, By Application:

  • Drug Discovery
  • Academics & Research

Human Liver Model Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Liver Model Market.

Available Customizations:

Global Human Liver Model market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Human Liver Model Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 5.2.2. By Application (Drug Discovery, Academics & Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Human Liver Model Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 6.2.2. By Application (Drug Discovery, Academics & Research)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Human Liver Model Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Human Liver Model Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Human Liver Model Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Human Liver Model Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 7.2.2. By Application (Drug Discovery, Academics & Research)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Human Liver Model Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Human Liver Model Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. France Human Liver Model Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Human Liver Model Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Human Liver Model Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia-Pacific Human Liver Model Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 8.2.2. By Application (Drug Discovery, Academics & Research)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Human Liver Model Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Human Liver Model Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. India Human Liver Model Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Human Liver Model Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Human Liver Model Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. South America Human Liver Model Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 9.2.2. By Application (Drug Discovery, Academics & Research)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Human Liver Model Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Human Liver Model Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Human Liver Model Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. Middle East and Africa Human Liver Model Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
    • 10.2.2. By Application (Drug Discovery, Academics & Research)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Human Liver Model Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Human Liver Model Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Human Liver Model Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Human Liver Model Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Organovo Holdings Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. BioIVT LLC
  • 14.3. InSphero AG
  • 14.4. Emulate Inc
  • 14.5. Mimetas BV
  • 14.6. CN Bio
  • 14.7. Cyfuse Biomedical KK
  • 14.8. Hurel Corp

15. Strategic Recommendations

16. About Us & Disclaimer